| |
| |
|
| Insider
Information: |
Last Andrew J. |
| Relationship: |
EVP, Chief Operating O... |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
97,890 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,650,600 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
97,890 |
|
|
| Total
Value |
$1,650,600 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -71.0%
|
-36.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Affymetrix Inc |
AFFX |
EVP, Chief Operating O... |
2016-03-31 |
0 |
|
0 |
Premium* |
|
|
Precigen Inc |
PGEN |
Chief Operating Officer |
2017-08-14 |
2,000 |
2017-08-14 |
0 |
Premium* |
|
|
Oncocyte Corp |
OCX |
Director |
2023-06-23 |
90,170 |
2018-07-26 |
0 |
Premium* |
|
|
Bio Rad Laboratories Inc |
BIO |
EVP, Chief Operating O... |
2024-04-29 |
5,720 |
2020-04-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
2,764 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2022-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
40,170 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2022-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
50,170 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2022-08-17 |
4 |
B |
$0.87 |
$17,400 |
D/D |
20,000 |
70,170 |
2.39 |
% |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
633 |
2,943 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2022-09-01 |
4 |
D |
$486.25 |
$152,683 |
D/D |
(314) |
2,629 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
902 |
3,531 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2022-09-02 |
4 |
D |
$478.32 |
$214,287 |
D/D |
(448) |
3,083 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2023-04-29 |
4 |
D |
$450.79 |
$155,973 |
D/D |
(346) |
3,767 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2023-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
4,113 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
90,170 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
4,864 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2023-09-01 |
4 |
D |
$394.60 |
$279,771 |
D/D |
(709) |
4,585 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
903 |
5,488 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2023-09-02 |
4 |
D |
$394.60 |
$176,781 |
D/D |
(448) |
5,040 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2024-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
6,077 |
0 |
- |
|
| BIO |
Bio Rad Laboratories Inc |
EVP, Chief Operating Officer |
• – – |
2024-04-29 |
4 |
D |
$277.11 |
$98,928 |
D/D |
(357) |
5,720 |
0 |
- |
|
67 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
